Technology area

Environmental & occupational health

1,251 funded awards, $793.4M total, FY2023-FY2025.

Data current as of 2026-05-11

Pattern read

This tag is the most diffuse in the dataset: 2.3% concentration at the top three recipients, the lowest of any tag. 1,251 records and $793M spread across the IC list. NIAID leads (241), NCI (172), and NHLBI (142). The tag captures environmental sensors, occupational-exposure monitoring, ambient air-quality tools, water testing, and adjacent work. NIEHS, the IC with the most natural fit, is not in the top three because NIEHS is a smaller SBIR funder by absolute dollars. Median award is $500K. Mechanism mix is healthy across R43/R44/R41.

Fit indicators

  • Extreme spread (2.3% concentration). No single dominant recipient; the field is wide open.
  • NIEHS is the natural fit, but NIAID and NCI have funded more environmental/occupational SBIR work in the dataset window because of their larger budgets.

Watchouts

  • The tag is broad enough that rule-based tagging captures peripheral work. Review the underlying record list before treating the tag as a category.
  • NIEHS-specific SBIR has a smaller dollar pool than the leading ICs. Budget realistically.

Where the money sat, by Institute / Center

IC funding decisions are set by portfolio priorities, NOFO scope, and program-officer judgment. These are funded records, not predictions of future funding.

ICNameRecordsMedian award
AI (NIAID) National Institute of Allergy and Infectious Diseases 241 $609,132
CA (NCI) National Cancer Institute 172 $819,461
HL (NHLBI) National Heart Lung and Blood Institute 142 $649,118
DK (NIDDK) National Institute of Diabetes and Digestive and Kidney Diseases 102 $600,059
AG (NIA) National Institute on Aging 101 $500,000
NS (NINDS) National Institute of Neurological Disorders and Stroke 77 $499,863
ES (NIEHS) National Institute of Environmental Health Sciences 76 $306,815
GM (NIGMS) National Institute of General Medical Sciences 58 $349,999
DA (NIDA) National Institute on Drug Abuse 50 $405,073
HD (NICHD) Eunice Kennedy Shriver National Institute of Child Health and Human Development 42 $388,250
AR (NIAMS) National Institute of Arthritis and Musculoskeletal and Skin Diseases 38 $306,858
EY (NEI) National Eye Institute 30 $606,040
MH (NIMH) National Institute of Mental Health 22 $532,845
TR (NCATS) National Center for Advancing Translational Sciences 21 $329,272
DE (NIDCR) National Institute of Dental and Craniofacial Research 16 $354,336
DC (NIDCD) National Institute on Deafness and Other Communication Disorders 12 $320,099
OD NIH Office of the Director 10 $641,606
EB (NIBIB) National Institute of Biomedical Imaging and Bioengineering 8 $877,654
AA (NIAAA) National Institute on Alcohol Abuse and Alcoholism 7 $605,404
AT (NCCIH) National Center for Complementary and Integrative Health 7 $306,793
LM (NLM) National Library of Medicine 6 $392,681
NR (NINR) National Institute of Nursing Research 6 $256,439
MD (NIMHD) National Institute on Minority Health and Health Disparities 6 $318,509
HG (NHGRI) National Human Genome Research Institute 1 $404,117

FOA / NOFO routes

Opportunity number prefixes: PA = Parent Announcement (broad, omnibus, multiple ICs), PAR = Parent with Special Review, PAS = Parent with set-aside funds, RFA = Request for Applications (targeted, single-IC, fixed budget). Status unknown means the pipeline has not verified whether the FOA is currently posting awards; the SBIR omnibus has been in reauthorization gap during this window. See the glossary for full definitions.

OpportunityStatusRecords
PA-22-176 unknown 249
PA-23-230 unknown 209
PA-21-259 unknown 148
PA-24-245 unknown 94
PA-22-178 unknown 87
PA-23-232 unknown 49
PA-24-247 unknown 36
PAS-22-196 unknown 30
PA-21-262 unknown 29
PA-20-260 unknown 28
PA-20-272 unknown 23
PA-20-265 unknown 16
PAS-22-197 unknown 15
PA-21-260 unknown 13
PAS-19-316 unknown 13
RFA-DA-23-021 unknown 12
PA-22-177 unknown 11
PAR-22-073 unknown 11
PA-19-272 unknown 10
RFA-HL-23-009 unknown 9
PA-24-246 unknown 9
PAR-21-225 unknown 8
PA-23-231 unknown 8
PA-21-345 unknown 8
RFA-DA-19-019 unknown 7
PA-19-270 unknown 6
PA-25-212 unknown 5
PAS-19-317 unknown 5
PA-20-262 unknown 4
RFA-ES-24-003 unknown 4
RFA-MD-23-003 unknown 4
RFA-NS-23-006 unknown 4
RFA-NS-23-007 unknown 4
RFA-CA-23-035 unknown 4
PA-22-179 unknown 4
PAR-23-032 unknown 4
RFA-CA-24-023 unknown 3
PAR-24-131 expired 3
PA-24-248 unknown 3
PA-18-819 unknown 3
PAR-20-244 unknown 3
PAR-21-266 unknown 3
RFA-MD-22-004 unknown 3
RFA-ES-22-004 unknown 3
RFA-DA-24-038 unknown 2
RFA-MD-24-006 unknown 2
RFA-AG-24-042 unknown 2
RFA-ES-21-008 unknown 2
RFA-CA-21-001 unknown 2
RFA-ES-23-005 unknown 2
PA-19-271 unknown 2
PAR-21-030 unknown 2
RFA-CA-22-025 unknown 2
PA-18-574 unknown 2
RFA-NS-20-009 unknown 2
RFA-ES-21-005 unknown 2
PA-20-261 unknown 2
RFA-HL-23-008 unknown 1
PAR-21-265 unknown 1
RFA-DA-25-053 unknown 1
RFA-CA-24-022 unknown 1
PA-24-254 unknown 1
RFA-MD-22-003 unknown 1
RFA-DA-24-017 unknown 1
RFA-ES-20-008 unknown 1
PAR-19-335 unknown 1
PAR-19-333 unknown 1
RFA-DA-22-023 unknown 1
RFA-DA-22-018 unknown 1
PA-18-566 unknown 1
RFA-DK-21-012 unknown 1
RFA-DK-19-027 unknown 1
RFA-NS-20-011 unknown 1
RFA-HL-19-017 unknown 1
RFA-ES-20-016 unknown 1
PA-18-575 unknown 1
PA-18-579 unknown 1
RFA-DA-23-017 unknown 1

Comparable funded projects

ApplIDFYICTitleOrganizationAmount
10825409 2025 OD Tools and Methods for Producing High Quality Functional Protein Microarrays for Biomarker Discovery SPOC PROTEOMICS INC. $1,370,834
10932426 2025 NS Kv2.1-Targeted First in Class Neuroprotective Therapeutic for Acute Ischemic Stroke CELDARA MEDICAL, LLC $421,106
11004996 2025 HL Improved Sirolimus-Analog Adventitial Delivery to Enhance Outcomes in Below-the-Knee Peripheral Artery Disease MERCATOR MEDSYSTEMS, INC. $1,000,000
11006781 2025 DE AntiXero: An extended duration solution for cancer-associated dry mouth. ANTIXERO $406,496
11007310 2025 AA An innovative, non-thiazolidinedione pan-PPAR agonist therapeutic for alcoholic hepatitis: IND-enabling safety and toxicological evaluation PLEIOGENIX INC. $1,025,643
11008422 2025 OD Transforming C. Elegans Research Through Gigahertz Ultrasonic Imaging Microscopy GEEGAH LLC $246,718
11011323 2025 HL Catheter for Complex Percutaneous Coronary Intervention CROSSLINER INC $990,619
11011333 2025 DK A Novel Anti-inflammatoryand Anti-oxidant Therapy for Treating Non-healing Diabetic Foot Ulcers CERIA THERAPEUTICS, INC. $1,034,376

Review panels that have appeared on these records

Panel names use NIH's Center for Scientific Review (CSR) format: a 2-4 letter study-section code plus a meeting-cycle number in parentheses (e.g. ISB (12) = Instrumentation and Systems Development, cycle 12). SBIR/STTR review groups are temporary, meeting-specific bodies. The names below describe panels that have appeared on the cited funded-project records, not where future applications get assigned. NIH assigns panels at the time of submission based on the application content.

Limitations

Want help with your NIH SBIR application?

Get started with Aims First →